{"id":"https://openalex.org/W2316515744","doi":"https://doi.org/10.1111/bjh.14031","title":"Significant improvement in overall survival among patients diagnosed with low\u2010risk myelodysplastic syndrome treated with selective serotonin reuptake inhibitors","display_name":"Significant improvement in overall survival among patients diagnosed with low\u2010risk myelodysplastic syndrome treated with selective serotonin reuptake inhibitors","publication_year":2016,"publication_date":"2016-04-07","ids":{"openalex":"https://openalex.org/W2316515744","doi":"https://doi.org/10.1111/bjh.14031","mag":"2316515744","pmid":"https://pubmed.ncbi.nlm.nih.gov/27061100"},"language":"en","primary_location":{"id":"doi:10.1111/bjh.14031","doi":"https://doi.org/10.1111/bjh.14031","is_oa":true,"landing_page_url":"https://doi.org/10.1111/bjh.14031","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bjh.14031","source":{"id":"https://openalex.org/S153015021","display_name":"British Journal of Haematology","issn_l":"0007-1048","issn":["0007-1048","1365-2141"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Haematology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bjh.14031","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5100413631","display_name":"Ang Li","orcid":"https://orcid.org/0000-0002-8455-2309","observed_orcids":["https://orcid.org/0000-0002-8455-2309"]},"institutions":[{"id":"https://openalex.org/I181547552","display_name":"Baylor College of Medicine","ror":"https://ror.org/02pttbw34","country_code":"US","type":"education","lineage":["https://openalex.org/I181547552","https://openalex.org/I2801539370"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ang Li","raw_affiliation_strings":["Section of Hematology/Oncology, Department of Medicine, Baylor College of Medicine, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Section of Hematology/Oncology, Department of Medicine, Baylor College of Medicine, Houston, TX, USA","institution_ids":["https://openalex.org/I181547552"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071390153","display_name":"Sarvari Venkata Yellapragada","orcid":"https://orcid.org/0000-0002-3262-8949","observed_orcids":["https://orcid.org/0000-0002-3262-8949"]},"institutions":[{"id":"https://openalex.org/I181547552","display_name":"Baylor College of Medicine","ror":"https://ror.org/02pttbw34","country_code":"US","type":"education","lineage":["https://openalex.org/I181547552","https://openalex.org/I2801539370"]},{"id":"https://openalex.org/I4390039366","display_name":"Dan L Duncan Comprehensive Cancer Center","ror":"https://ror.org/02nre0x31","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I181547552","https://openalex.org/I2801539370","https://openalex.org/I4390039366"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sarvari V. Yellapragada","raw_affiliation_strings":["Section of Hematology/Oncology, Department of Medicine, Baylor College of Medicine, Houston, TX, USA","The Dan L. Duncan Comprehensive Cancer Center at Baylor College of Medicine, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Section of Hematology/Oncology, Department of Medicine, Baylor College of Medicine, Houston, TX, USA","institution_ids":["https://openalex.org/I181547552"]},{"raw_affiliation_string":"The Dan L. Duncan Comprehensive Cancer Center at Baylor College of Medicine, Houston, TX, USA","institution_ids":["https://openalex.org/I4390039366"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110886100","display_name":"Martha Pritchett Mims","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I181547552","display_name":"Baylor College of Medicine","ror":"https://ror.org/02pttbw34","country_code":"US","type":"education","lineage":["https://openalex.org/I181547552","https://openalex.org/I2801539370"]},{"id":"https://openalex.org/I4390039366","display_name":"Dan L Duncan Comprehensive Cancer Center","ror":"https://ror.org/02nre0x31","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I181547552","https://openalex.org/I2801539370","https://openalex.org/I4390039366"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Martha Mims","raw_affiliation_strings":["Section of Hematology/Oncology, Department of Medicine, Baylor College of Medicine, Houston, TX, USA","The Dan L. Duncan Comprehensive Cancer Center at Baylor College of Medicine, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Section of Hematology/Oncology, Department of Medicine, Baylor College of Medicine, Houston, TX, USA","institution_ids":["https://openalex.org/I181547552"]},{"raw_affiliation_string":"The Dan L. Duncan Comprehensive Cancer Center at Baylor College of Medicine, Houston, TX, USA","institution_ids":["https://openalex.org/I4390039366"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108421331","display_name":"Anna Frolov","orcid":"https://orcid.org/0000-0002-7617-7852","observed_orcids":["https://orcid.org/0000-0002-7617-7852"]},"institutions":[{"id":"https://openalex.org/I181547552","display_name":"Baylor College of Medicine","ror":"https://ror.org/02pttbw34","country_code":"US","type":"education","lineage":["https://openalex.org/I181547552","https://openalex.org/I2801539370"]},{"id":"https://openalex.org/I4390039366","display_name":"Dan L Duncan Comprehensive Cancer Center","ror":"https://ror.org/02nre0x31","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I181547552","https://openalex.org/I2801539370","https://openalex.org/I4390039366"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anna Frolov","raw_affiliation_strings":["Section of Hematology/Oncology, Department of Medicine, Baylor College of Medicine, Houston, TX, USA","The Dan L. Duncan Comprehensive Cancer Center at Baylor College of Medicine, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Section of Hematology/Oncology, Department of Medicine, Baylor College of Medicine, Houston, TX, USA","institution_ids":["https://openalex.org/I181547552"]},{"raw_affiliation_string":"The Dan L. Duncan Comprehensive Cancer Center at Baylor College of Medicine, Houston, TX, USA","institution_ids":["https://openalex.org/I4390039366"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5059002977","display_name":"Gustavo Rivero","orcid":"https://orcid.org/0000-0002-2866-9203","observed_orcids":["https://orcid.org/0000-0002-2866-9203"]},"institutions":[{"id":"https://openalex.org/I181547552","display_name":"Baylor College of Medicine","ror":"https://ror.org/02pttbw34","country_code":"US","type":"education","lineage":["https://openalex.org/I181547552","https://openalex.org/I2801539370"]},{"id":"https://openalex.org/I4390039366","display_name":"Dan L Duncan Comprehensive Cancer Center","ror":"https://ror.org/02nre0x31","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I181547552","https://openalex.org/I2801539370","https://openalex.org/I4390039366"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gustavo A. Rivero","raw_affiliation_strings":["Section of Hematology/Oncology, Department of Medicine, Baylor College of Medicine, Houston, TX, USA","The Dan L. Duncan Comprehensive Cancer Center at Baylor College of Medicine, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Section of Hematology/Oncology, Department of Medicine, Baylor College of Medicine, Houston, TX, USA","institution_ids":["https://openalex.org/I181547552"]},{"raw_affiliation_string":"The Dan L. Duncan Comprehensive Cancer Center at Baylor College of Medicine, Houston, TX, USA","institution_ids":["https://openalex.org/I4390039366"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5190,"currency":"USD","value_usd":5190},"apc_paid":null,"fwci":0.9507,"has_fulltext":true,"cited_by_count":4,"citation_normalized_percentile":{"value":0.7871936,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":94},"biblio":{"volume":"177","issue":"1","first_page":"142","last_page":"144"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9613999724388123,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9613999724388123,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10178","display_name":"Cancer survivorship and care","score":0.002199999988079071,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11559","display_name":"Retinoids in leukemia and cellular processes","score":0.002199999988079071,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/myelodysplastic-syndrome","display_name":"myelodysplastic syndrome","score":0.9729999899864197},{"id":"https://openalex.org/keywords/lower-risk-myelodysplastic-syndromes","display_name":"lower-risk myelodysplastic syndromes","score":0.9430000185966492},{"id":"https://openalex.org/keywords/selective-serotonin-reuptake-inhibitors","display_name":"selective serotonin reuptake inhibitors","score":0.9980000257492065},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9259999990463257},{"id":"https://openalex.org/keywords/antidepressant-treatment","display_name":"antidepressant treatment","score":0.5860000252723694}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.606837272644043},{"id":"https://openalex.org/C2910584757","wikidata":"https://www.wikidata.org/wiki/Q334477","display_name":"Serotonin Uptake Inhibitors","level":5,"score":0.5709846615791321},{"id":"https://openalex.org/C2780817109","wikidata":"https://www.wikidata.org/wiki/Q954625","display_name":"Myelodysplastic syndromes","level":3,"score":0.5632930397987366},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5563852190971375},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5337551236152649},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.4366605281829834},{"id":"https://openalex.org/C31487548","wikidata":"https://www.wikidata.org/wiki/Q4859664","display_name":"Reuptake inhibitor","level":4,"score":0.4152151346206665},{"id":"https://openalex.org/C2776134451","wikidata":"https://www.wikidata.org/wiki/Q422244","display_name":"Fluoxetine","level":4,"score":0.15552574396133423},{"id":"https://openalex.org/C2780007613","wikidata":"https://www.wikidata.org/wiki/Q546523","display_name":"Bone marrow","level":2,"score":0.0618416965007782},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009190","descriptor_name":"Myelodysplastic Syndromes","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D009190","descriptor_name":"Myelodysplastic Syndromes","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009190","descriptor_name":"Myelodysplastic Syndromes","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":true},{"descriptor_ui":"D015996","descriptor_name":"Survival Rate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016016","descriptor_name":"Proportional Hazards Models","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017367","descriptor_name":"Selective Serotonin Reuptake Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1111/bjh.14031","doi":"https://doi.org/10.1111/bjh.14031","is_oa":true,"landing_page_url":"https://doi.org/10.1111/bjh.14031","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bjh.14031","source":{"id":"https://openalex.org/S153015021","display_name":"British Journal of Haematology","issn_l":"0007-1048","issn":["0007-1048","1365-2141"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Haematology","raw_type":"journal-article"},{"id":"pmid:27061100","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/27061100","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of haematology","raw_type":"Letter"}],"best_oa_location":{"id":"doi:10.1111/bjh.14031","doi":"https://doi.org/10.1111/bjh.14031","is_oa":true,"landing_page_url":"https://doi.org/10.1111/bjh.14031","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bjh.14031","source":{"id":"https://openalex.org/S153015021","display_name":"British Journal of Haematology","issn_l":"0007-1048","issn":["0007-1048","1365-2141"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Haematology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320309326","display_name":"Golfers Against Cancer","ror":"https://ror.org/05tte0y64"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2316515744.pdf","grobid_xml":"https://content.openalex.org/works/W2316515744.grobid-xml"},"referenced_works_count":10,"referenced_works":["https://openalex.org/W1670369534","https://openalex.org/W1971595958","https://openalex.org/W1998520631","https://openalex.org/W2007811606","https://openalex.org/W2028419347","https://openalex.org/W2032477348","https://openalex.org/W2063161726","https://openalex.org/W2087162322","https://openalex.org/W2127108097","https://openalex.org/W2131095909"],"related_works":["https://openalex.org/W2551043062","https://openalex.org/W2336915120","https://openalex.org/W1022699249","https://openalex.org/W2780282110","https://openalex.org/W2200662048","https://openalex.org/W3214834078","https://openalex.org/W2953689383","https://openalex.org/W4281723540","https://openalex.org/W7171476423","https://openalex.org/W2089770204"],"abstract_inverted_index":{"Low":[0],"risk":[1,247,260,448,513,580],"myelodysplaastic":[2],"syndrome":[3],"(LR-MDS)":[4],"is":[5,56,591,719,736,999],"observed":[6,57,253,274],"in":[7,44,58,76,105,154,194,263,275,305,312,417,432,451,488,495,506,563,602,619,648,667,761,776,794,847,957,975,992,1014,1036],"elderly":[8,548],"patients":[9,116,135,149,244,298,347,382,390,400,423,436,454,481,546,567,584,603,762,780,928,944,1012,1037],"and":[10,23,35,61,64,102,120,206,309,328,364,389,397,492,503,540,549,606,611,630,663,692,759,770,773,797,869,936,1005,1074,1077,1088],"characterized":[11],"by":[12,78,819,942,1047],"symptomatic":[13],"cytopenias.":[14],"Molecular":[15],"studies":[16],"highlight":[17],"a":[18,137,531,560,576,668,725,835,921,950,993,1025],"central":[19],"role":[20,789],"for":[21,297,359,404,480,551,565,583,683,800,808,855,917,927,939,1042],"apoptosis":[22,735],"immune":[24,821,894],"deregulation.":[25],"The":[26,185,259,293,476,963],"capacity":[27],"of":[28,73,166,209,261,334,362,449,462,511,538,578,581,645,711,740,753,779,790,817,825,843,850,891,947,986,1010,1031,1098],"cytokines,":[29],"such":[30,866],"as":[31,190,331,353,823,867,871],"IL6,":[32,609],"TNF-":[33],"\u03b1":[34],"INF-\u04af":[36],"to":[37,51,152,180,200,355,515,520,534,616,707,730,982,1033,1100],"sustain":[38],"ineffective":[39,712,732],"haematopoiesis":[40],"suggests":[41,798,881],"that":[42,96,273,346,461,592,638,656,698,721,837,882,1001],"intervention":[43],"this":[45,555,639,1021,1043],"pathway":[46,861],"could":[47,98,884],"provide":[48],"benefit.":[49],"Similar":[50],"LR-MDS,":[52],"deregulated":[53,791],"cytokine":[54,80,597,646,726],"signalling":[55,598,749,860],"both":[59],"depression":[60,605,765,1004],"rheumatoid":[62,607],"arthritis":[63],"selective":[65],"serotonin":[66],"reuptake":[67],"inhibitors":[68,874],"(SSRIs)":[69],"abrogate":[70],"the":[71,125,155,176,215,242,264,276,306,313,360,447,463,489,496,535,579,788,815,892,970,976,984,1007,1029,1048,1057,1064,1071,1079,1090],"symptoms":[72],"these":[74,620],"disorders":[75,827],"part":[77],"modulating":[79],"abnormalities":[81],"(Sutcigil":[82],"et":[83,87,91,634,651,715,767,784,876,897],"al,":[84,88,92,635,716,768,785,877,898],"2007;":[85],"Baharav":[86],"2012;":[89],"Taraz":[90],"2013).":[93],"We":[94],"hypothesized":[95],"SSRIs":[97,350,593,903,1002,1032],"delay":[99],"disease":[100,301,484,795],"progression":[101],"prolong":[103],"survival":[104,192,905,924,954,991,1034],"LR-MDS":[106,148,529,566,669,1011],"patients.":[107],"After":[108,915],"Institutional":[109],"Review":[110],"Board":[111],"approval,":[112],"118":[113],"primary":[114,186,539],"MDS":[115,183,545,782,851],"aged":[117],"18":[118],"years":[119],"older":[121],"were":[122,150,212,223,235,252,351,392,428],"identified":[123,320,863],"from":[124,196,202,415,626,988],"Michael":[126],"E.":[127],"DeBakey":[128],"VA":[129],"Medical":[130],"Center":[131],"cancer":[132,1052],"registry.":[133],"Eighty-seven":[134],"had":[136,160,384,911],"low":[138,246],"or":[139,173,908],"intermediate-1":[140],"International":[141],"Prognostic":[142],"Scoring":[143],"System":[144],"score":[145],"(i.e.,":[146],"lower-risk).":[147],"considered":[151,236],"be":[153,617],"SSRI+":[156,255,307,396,443,490,977],"group":[157,266,278,308,315,465,491],"if":[158],"they":[159],"received":[161,385,912],"at":[162],"least":[163],"6":[164],"months":[165,178,304,311,487,494,685],"an":[167,507,688],"SSRI":[168,210,321,516,722,987],"(including":[169],"fluoxetine,":[170],"sertraline,":[171],"paroxetine":[172],"citalopram)":[174],"during":[175],"12":[177],"prior":[179],"and/or":[181],"after":[182,357,686,937],"diagnosis.":[184],"outcome":[187,906],"was":[188,267,302,379,455,485,525,659,681,925,955,1045],"defined":[189],"overall":[191],"(OS),":[193],"days,":[195],"bone":[197,741],"marrow":[198,742],"diagnosis":[199],"death":[201,262,450,512],"any":[203],"cause.":[204],"Univariate":[205],"multivariate":[207,338,961],"analysis":[208,319,378,500],"effect":[211,361,728,887,985],"performed":[213,224,1070],"using":[214],"Cox":[216,337],"proportional":[217],"hazards":[218],"regression":[219],"model.":[220],"Statistical":[221],"analyses":[222],"with":[225,245,299,424,437,482,569,595,600,604,661,671,674,701,738,763,781,945,1038],"spss":[226],"22.0":[227],"(IBM":[228],"Corp.,":[229],"Armonk,":[230],"NY,":[231],"USA).":[232],"P":[233,290,373,408,473],"values":[234],"statistically":[237,527],"significant":[238,343,561,953],"when":[239],"<0\u00b705.":[240],"Among":[241],"87":[243],"disease,":[248],"balanced":[249,393],"baseline":[250],"characteristics":[251,391],"(15":[254],"vs.":[256,444],"72":[257],"SSRI\u2212).":[258],"non-SSRI":[265,452],"almost":[268,456,508],"2\u00b74":[269],"times":[270,458],"higher":[271,459],"than":[272,460,575],"treated":[277,453,464,568],"[Hazard":[279],"ratio":[280],"(HR)":[281],"=":[282,288,291,367,374,409,467,471,474],"2\u00b738,":[283],"95%":[284,369,469],"confidence":[285],"interval":[286],"(CI)":[287],"1\u00b720\u20134\u00b771,":[289],"0\u00b70128].":[292],"estimated":[294,477],"median":[295,478],"OS":[296,479,564],"lower-risk":[300,483],"57\u00b75":[303],"23\u00b79":[310],"SSRI\u2212":[314,399,497],"(Fig":[316],"1A).":[317],"Multivariate":[318,499],"use,":[322],"white":[323],"blood":[324],"cell":[325],"(WBC)":[326],"count":[327],"haemoglobin":[329],"(Hb)":[330],"independent":[332],"predictors":[333,344],"survival.":[335,1018],"A":[336,376],"model":[339],"containing":[340],"all":[341],"3":[342,859],"demonstrated":[345],"not":[348,526,585,909,960],"taking":[349,586,929],"twice":[352],"likely":[354],"die,":[356],"controlling":[358,938],"Hb":[363,405,418,425,502,973,989],"WBC":[365,504],"[HR":[366],"2\u00b7082,":[368],"CI":[370,470],"(1\u00b7042,":[371],"4\u00b7158),":[372],"0\u00b70378].":[375],"similar":[377,951],"repeated":[380],"excluding":[381],"who":[383],"disease-modifying":[386,913],"agents.":[387,914],"Demographics":[388],"among":[394,435],"8":[395],"47":[398],"(Table":[401],"1),":[402],"except":[403],"level":[406,695,974],"(Mann\u2013Whitney":[407],"0\u00b7027).":[410],"To":[411],"prevent":[412],"potential":[413,840,872,919,940],"bias":[414,941],"difference":[416],"levels":[419,613],"between":[420],"groups,":[421],"only":[422,441],">70":[426],"g/l":[427],"included.":[429],"As":[430],"shown":[431],"Fig":[433],"1B,":[434],"best":[438],"supportive":[439],"care":[440],"(8":[442],"41":[445],"SSRI\u2212),":[446],"2\u00b78":[457],"(HR":[466],"2\u00b781,":[468],"1\u00b705\u20137\u00b750,":[472],"0\u00b70390).":[475],"63\u00b71":[486],"31\u00b76":[493],"group.":[498],"including":[501],"resulted":[505],"identical":[509],"estimate":[510],"due":[514,519,533],"status,":[517],"but,":[518],"small":[521,933,994],"sample":[522,934],"size,":[523,935],"it":[524,980,998],"significant.":[528],"remains":[530],"challenge":[532],"high":[536,751],"frequency":[537],"secondary":[541],"drug":[542],"failure.":[543],"Many":[544],"are":[547,614],"unsuitable":[550],"intensive":[552],"treatment.":[553],"In":[554,745,900,996],"retrospective":[556],"study,":[557,902],"we":[558],"detected":[559],"improvement":[562,679],"SSRIs.":[570,587,930],"This":[571,879],"translated":[572],"into":[573],"more":[574],"doubling":[577],"dying":[582],"An":[588],"interesting":[589],"observation":[590,880,1023],"interfere":[594],"abnormal":[596,618,748],"associated":[599,660,737],"inflammation":[601],"arthritis.":[608],"IL12":[610],"TNF-\u03b1":[612,624],"known":[615],"disorders.":[621],"Sertraline":[622],"decreases":[623],"release":[625],"human":[627],"T-cell":[628],"lymphocytes":[629],"(IFN)-\u03b3-activated":[631],"microglia":[632],"(Taler":[633],"2007),":[636],"suggesting":[637,697],"mechanism":[640],"might":[641],"also":[642],"facilitate":[643],"resolution":[644],"deregulation":[647],"MDS.":[649],"Nautiyal":[650],"al":[652],"(2014)":[653],"recently":[654],"reported":[655,1094],"sertraline":[657,699,868,883],"treatment":[658],"transfusion":[662],"growth":[664],"factor":[665,706,858],"independence":[666],"patient":[670],"refractory":[672],"cytopenia":[673],"multilineage":[675],"dysplasia.":[676],"Erythroid":[677],"haematological":[678],"(HI-E)":[680],"sustained":[682],"11":[684],"discontinuing":[687],"erythropoiesis-stimulating":[689],"agent":[690],"(ESA),":[691],"endogenous":[693],"erythropoietin":[694],"normalized,":[696],"cooperated":[700],"ESA":[702],"plus":[703],"granulocyte":[704],"colony-stimulating":[705],"resolve":[708],"severe":[709],"manifestations":[710],"haematopoeisis":[713],"(Nautiyal":[714],"2014).":[717],"It":[718],"possible":[720,1000],"administration":[723],"exerts":[724],"regulatory":[727,857],"leading":[729],"improved":[731],"haematopoiesis.":[733],"Excessive":[734],"amplification":[739,849],"inflammatory":[743,848],"response.":[744],"recent":[746],"years,":[747],"via":[750,888],"expression":[752],"Toll-like":[754],"receptor":[755],"(TLR)":[756],"3,":[757],"4":[758],"7":[760],"major":[764],"(Hung":[766],"2014)":[769],"TLR1,":[771],"TLR2":[772],"TLR6":[774],"overexpression":[775],"CD34+":[777],"cells":[778],"(Wei":[783],"2013)":[786],"highlights":[787],"innate":[792,820,893],"immunity":[793],"pathogenesis":[796],"possibility":[799],"therapeutic":[801],"intervention.":[802],"Although":[803],"endosomal":[804],"TLRs":[805],"retain":[806],"affinity":[807],"pathogens-associated":[809],"molecular":[810],"patterns,":[811],"increasing":[812],"evidence":[813],"supports":[814],"recognition":[816],"self-ligands":[818],"receptors":[822],"effector":[824],"autoimmune":[826],"(de":[828],"Alba,":[829],"2009;":[830],"Lee":[831],"&":[832],"Barton,":[833],"2014),":[834],"concept":[836],"intuitively":[838],"links":[839],"defective":[841],"processing":[842],"host-derived":[844],"nucleic":[845],"acids":[846],"pathogenesis.":[852],"High-throughput":[853],"screening":[854],"TLR3-INF":[856],"modulators":[862],"antipsychotic":[864],"medications,":[865],"trifluoperazine,":[870],"TLR":[873],"(Zhu":[875,896],"2010).":[878,899],"execute":[885],"anti-inflammatory":[886],"direct":[889,1015],"inhibition":[890],"signaling":[895],"our":[901,932],"influenced":[904],"whether":[907],"subjects":[910],"adjustment":[916],"multiple":[918],"covariates,":[920],"substantial":[922],"favourable":[923,952],"retained":[926],"Acknowledging":[931],"removing":[943],"co-administration":[946],"MDS-modifying":[948],"agents,":[949],"maintained":[956],"univariate,":[958],"but":[959],"analysis.":[962],"present":[964],"study":[965,1044],"has":[966],"limitations,":[967],"which":[968],"include":[969],"highly":[971],"variable":[972],"group,":[978],"making":[979],"difficult":[981],"distinguish":[983],"on":[990,1017],"sample.":[995],"addition,":[997],"improve":[1003],"influence":[1006],"physiological":[1008],"well-being":[1009],"resulting":[1013],"impact":[1016],"That":[1019],"said,":[1020],"provocative":[1022],"provides":[1024],"preliminary":[1026],"framework":[1027],"linking":[1028],"use":[1030],"benefit":[1035],"myelodysplasia.":[1039],"Financial":[1040],"support":[1041],"provided":[1046],"Texas":[1049],"Golfers":[1050],"Against":[1051],"grant":[1053],"funding.":[1054],"GR":[1055,1073],"conceived":[1056],"study;":[1058],"GR,":[1059,1068,1081],"AL,":[1060,1066,1082],"SY,":[1061,1067,1084],"MM":[1062],"designed":[1063],"research;":[1065,1072],"AF":[1069,1075,1085],"analysed":[1076],"interpreted":[1078],"results;":[1080],"MM,":[1083],"wrote,":[1086],"reviewed":[1087],"approved":[1089],"manuscript.":[1091],"All":[1092],"authors":[1093],"no":[1095],"relevant":[1096],"conflict":[1097],"interest":[1099],"disclose.":[1101]},"counts_by_year":[{"year":2021,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}